
Sign up to save your podcasts
Or


2020 seems to be the year of the evolution of the atypical, newfangled CDMO. Outsourced Pharma Chief Editor Louis Garguilo talks about this trend and what makes these new models all the rage.
By Life Science Connect2020 seems to be the year of the evolution of the atypical, newfangled CDMO. Outsourced Pharma Chief Editor Louis Garguilo talks about this trend and what makes these new models all the rage.